Jaguar Health (NASDAQ:JAGX) | WebDisclosure

Basculer en Français

8396	Companies
122097	Keywords
60577	Articles
65553	Press releases

Home
Companies
Jaguar Health

BRIEF

published on 08/19/2024 at 16:05, 4 months 2 days ago

Jaguar Health obtient un nouveau brevet pour Crofelemer à Hong Kong

Crofelemer Brevet Médicaments Santé Jaguar Syndrome De L'intestin Court
BRIEF

published on 08/19/2024 at 16:05, 4 months 2 days ago

Jaguar Health Secures New Patent for Crofelemer in Hong Kong

Crofelemer Short Bowel Syndrome Pharmaceuticals Patent Jaguar Health
PRESS RELEASE

published on 08/19/2024 at 16:00, 4 months 2 days ago

Issuance of New Hong Kong Patent Bolsters IP Protection for Jaguar Health in the Treatment of Short Bowel Syndrome (SBS)
New patent issued for core rare disease target indication for crofelemer by Jaguar Health, enhancing intellectual property protection. Proof-of-concept studies ongoing for SBS and MVID

Crofelemer Patent Jaguar Health Rare Disease Proof-of-Concept Studies
BRIEF

published on 08/13/2024 at 14:05, 4 months 8 days ago

Jaguar Health publie ses résultats financiers du deuxième trimestre 2024

Résultats Financiers Santé Jaguar Essais De Phase 3 Chiffre D'affaires 2024 Produits Sur Ordonnance
BRIEF

published on 08/13/2024 at 14:05, 4 months 8 days ago

Jaguar Health Reports Second Quarter 2024 Financial Results

Financial Results Jaguar Health Phase 3 Trials 2024 Revenue Prescription Products
PRESS RELEASE

published on 08/13/2024 at 14:00, 4 months 8 days ago

Jaguar Health Reports Second Quarter 2024 Financial Results
Jaguar Health, Inc. reports a 16% revenue increase in Q2 2024 for prescription and non-prescription products. Company explores approval pathways for crofelemer in rare diseases, plans commercial launch of Gelclair in October 2024

Revenue Increase Crofelemer Jaguar Health Q2 2024 Gelclair
BRIEF

published on 08/01/2024 at 15:05, 4 months 20 days ago

Crofelemer de Jaguar Health montre des résultats prometteurs pour la diarrhée chronique

Crofelemer Essais Cliniques Gastro-entérologie Diarrhée Fonctionnelle Diarrhée Chronique
BRIEF

published on 08/01/2024 at 15:05, 4 months 20 days ago

Jaguar Health's Crofelemer Shows Promising Results for Chronic Diarrhea

Crofelemer Clinical Trials Gastroenterology Functional Diarrhea Chronic Diarrhea
PRESS RELEASE

published on 08/01/2024 at 15:00, 4 months 20 days ago

Two Investigator-Initiated Responder Analysis Trials of Jaguar Health's Crofelemer Show Significant Positive Results for Chronic Refractory Diarrhea in IBS-D: Data Accepted for Presentation at American College of Gastroenterology 2024 Annual Meeting
Napo Pharmaceuticals announced positive results of studies on crofelemer for chronic refractory diarrhea at the ACG Annual Scientific Meeting. The drug may benefit patients with functional diarrhea and chronic idiopathic diarrhea

Napo Pharmaceuticals Crofelemer Functional Diarrhea ACG Annual Scientific Meeting Chronic Refractory Diarrhea
BRIEF

published on 07/31/2024 at 16:05, 4 months 21 days ago

La délivrance d'un nouveau brevet européen renforce la protection de la propriété intellectuelle de Jaguar Health dans le traitement des troubles diarrhéiques congénitaux (CDD)

Crofelemer Santé Jaguar Brevet Européen CDD Études De Validation De Principe

Accesswire

Published on 12/21/2024 at 01:30, 17 hours 43 minutes ago

Quantum Biopharma Announces Closing of Second Tranche
Published on 12/21/2024 at 01:30, 17 hours 43 minutes ago

iMetal Resources Closes First Tranche of Previously Announced Non-Brokered Private Placement
Published on 12/21/2024 at 00:05, 19 hours 8 minutes ago

Chloeta Awarded GSA OASIS+ IDIQ Contract for Intelligence, Federal Civilian and Defense Support Services
Published on 12/21/2024 at 00:00, 19 hours 13 minutes ago

Amarc Announces Loan Extension
Published on 12/20/2024 at 23:30, 19 hours 43 minutes ago

Boron One Announces Extension to Early Warrant Exercise Incentive Program

View all ACCESSWIRE

EQS Group

Published on 12/21/2024 at 00:51, 18 hours 21 minutes ago

Acquisition of PSI Transcom GmbH by CHAPTERS platform Altamount Software GmbH
Published on 12/21/2024 at 00:45, 18 hours 27 minutes ago

EQS-Adhoc: PSI sells the Mobility business unit
Published on 12/20/2024 at 19:10, 1 day ago

Funding Circle Plc: POS-Transaction in Own Shares
Published on 12/20/2024 at 18:56, 1 day ago

CPI PROPERTY GROUP – Progress on Key Initiatives
Published on 12/20/2024 at 18:00, 1 day 1 hour ago

ARYZTA AG Announces New Board Technology Committee

Les Echos

Published on 12/21/2024 at 12:17, 6 hours 55 minutes ago

AXA annonce la signature d’un accord relatif à la vente d'AXA Investment Managers à BNP Paribas
Published on 12/21/2024 at 12:17, 6 hours 55 minutes ago

AXA announces the signing of a share purchase agreement with BNP Paribas relating to the sale of AXA IM
Published on 12/20/2024 at 18:00, 1 day 1 hour ago

Kapitaalverhoging door uitoefening van inschrijvingsrechten
Published on 12/20/2024 at 18:00, 1 day 1 hour ago

Capital increase through exercise of subscription rights
Published on 12/20/2024 at 17:55, 1 day 1 hour ago

Déclaration des transactions sur actions propres réalisées du 16/12/2024 au 20/12/2024

View all LES ECHOS COMFI WIRE